BTBerrin Tuğrul

Berrin Tuğrul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Berrin Tuğrul has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combined Effects of Fluoxetine and Temozolomide on Apoptosis, Autophagy and Migration in Human Glioblastoma Cells

    by Berrin Tuğrul, Dilan Odabaş, Fatih Çöllü

    Glioblastoma multiforme (GBM) is an aggressive central nervous system tumor associated with poor prognosis and resistance to conventional therapies. This study investigated the cytotoxic and mechanistic effects of the selective serotonin reuptake inhibitor fluoxetine (FLT), alone and in combination with the alkylating agent temozolomide (TMZ), in human glioblastoma T98-G cells and non-tumorigenic human embryonic kidney HEK-293 cells. Cell viability, apoptotic cell death, cell migration, autophagic activity, and mitochondrial membrane potential were assessed using the MTT assay, Annexin V-FITC/PI staining, wound healing assay, monodansylcadaverine (MDC), and JC-1 staining, respectively. Quantitative image analyses were performed with ImageJ, and drug interaction effects were assessed using ComboSyn software. FLT significantly reduced cell viability in T98-G cells (IC₅₀: 36 µM), whereas HEK-293 cells exhibited markedly lower sensitivity (IC₅₀: 320 µM). In glioblastoma cells, FLT and TMZ, particularly in combination, predominantly induced late-stage apoptosis, while early apoptotic responses were more pronounced in HEK-293 cells. Combined treatment resulted in 36.4% late apoptosis in T98-G cells and 16.5% early apoptosis in HEK-293 cells. Both agents significantly inhibited cell migration, with the strongest suppression observed following combination treatment. At 24 hours, all treatments induced autophagic alterations and mitochondrial membrane depolarization. At 48 hours, autophagic activity persisted mainly in single-agent treatments, whereas mitochondrial dysfunction remained evident across all groups. Overall, FLT exerts cytotoxic effects in glioblastoma cells through apoptosis induction, mitochondrial dysfunction, modulation of autophagy, and inhibition of cell migration. These effects are enhanced when combined with TMZ, suggesting that fluoxetine may represent a promising adjuvant candidate for GBM therapy and warrants further in vivo investigation.

  • Targeting Prion Protein to Overcome Doxorubicin Resistance in SCLC

    by Fatih Çöllü, Hayrettin Kadinşah, Zübeyde Öztel, Berrin Tuğrul, Erdal Balcan

    Multidrug resistance (MDR) remains a major challenge in small cell lung cancer (SCLC), limiting the efficacy of chemotherapeutics like doxorubicin. This study investigates whether silencing cellular prion protein (PrP), a known MDR‐associated molecule, can enhance doxorubicin‐induced cell death in Adriamycin‐resistant H69AR cells. Quantitative RT‐PCR and immunocytochemistry were used to assess the expression of PRNP , CD44 , BAX , and BECN1 under various treatment conditions, including doxorubicin exposure and PrP knockdown via siRNA. Autophagic activity was evaluated using monodansylcadaverine (MDC) staining. PrP knockdown significantly reduced PRNP expression and modulated CD44 mRNA levels, especially during doxorubicin co‐treatment. However, CD44 protein levels remained unchanged, suggesting post‐transcriptional regulation. BAX expression increased with doxorubicin and siRNA individually, but not in combination, indicating a PrP‐independent mechanism. BECN1 expression and Beclin‐1 protein levels were significantly elevated in all treatment groups, especially in siRNA/doxorubicin combination. MDC staining confirmed increased autophagic vacuole formation in this group, indicating activation of Beclin‐1‐mediated autophagy. In conclusion, PrP knockdown may sensitize resistant SCLC cells to doxorubicin and promote autophagy. These findings support PrP silencing as a promising strategy to reverse chemoresistance in SCLC.

  • Open Access

    Effects of Combined Artemisia absinthium and Temozolomide Treatment on Apoptosis, Autophagy, and Nitric Oxide Synthase in Glioblastoma

    by Berrin Tuğrul, Fatih Çöllü, Beyhan Gürcü

    Artemisia absinthium (wormwood; WO) is a plant known for its anticancer potential and this study comprehensively evaluates the effects of WO, alone and in combination with Temozolomide (TMZ), on cytotoxicity, apoptosis, autophagy, mitochondrial membrane potential, cell migration, and nitric oxide synthase (NOS) responses in T98-G glioblastoma cells. Cytotoxicity, apoptosis, autophagy, mitochondrial membrane potential, and cell migration were assessed using MTT, Annexin V-FITC/PI, JC-1, monodansylcadaverine (MDC) staining, and wound healing assay, respectively. Protein levels of eNOS, iNOS, and LC3-II were examined using immunofluorescence and western blotting. WO significantly reduced T98-G cell viability in a dose- and time-dependent manner with pronounced cytotoxicity observed at 48 and 72 hours. The combined treatment increased early (24.6%) and late (40.5%) apoptosis, reducing cell viability to 31.9%. Combined treatment markedly increased autophagic vacuoles, enhancing perinuclear and cytoplasmic accumulation compared with single agents. Combined WO and TMZ treatment disrupted mitochondrial membrane potential more prominently than either agent alone, suggesting that apoptosis is mediated via the mitochondrial pathway. WO strongly inhibited T98-G cell migration, whereas TMZ and the combination had moderate suppressive effects. In T98-G cells, WO IC₅₀ significantly increased eNOS (p<0.0001), iNOS (p<0.0001), and LC3 (p<0.01), while TMZ IC₅₀ moderately increased iNOS (p<0.05) and combined treatment maximally elevated iNOS and LC3 (p<0.0001) without further affecting eNOS. Preliminary Western blot analyses qualitatively corroborated the immunofluorescence data, indicating consistent treatment-dependent trends in eNOS, iNOS, and LC3-II expression. These findings highlight the potential of WO in enhancing TMZ efficacy and provide a basis for further investigation in glioblastoma therapy.

  • The Root Extracts of Valeriana Officinalis L. may Control Programmed Cell Death Pathways in Breast Cancer Cell Line, MCF-7

    by Delfin Alpsoy, Berrin Tuğrul, Zübeyde Öztel, Erdal Balcan

    Natural product-derived phytochemicals are now accepted as promising agents in developing new strategies for cancer treatment and prevention. The root extracts of valerian (Valeriana officinalis L.), which is a supplement widely used for improving circadian rhythm-dependent sleep disorders and insomnia, might be a good candidate in that context. In the present study we hypothesized whether extract of valerian root induce programmed cell death machineries in a human breast cancer model, MCF-7 cells. To test the hypothesis, we treated MCF-7 cells with the extract at different concentrations for 24 h. Giemsa staining was used to evaluate the apoptotic morphology and apoptotic index, and monodancylcadaverine assay was used to determine vacuoles that are associated with autophagic flux. Our results indicated that extracts of the roots of valerian have apototic and autophagic effect on human breast cancer cell MCF-7 in a dose dependent manner. Moreover, the typical cobblestone morphology of the cells was disrupted after the extract treatments and the cells lost contact with each other. This morphological alteration was attributed to anoikis, is a programmed cell death type induced by loss of cell communication with extracellular matrix or neighboring cells. In conclusion, although this study has many methodological shortcomings, our findings suggest that Valeriana officinalis L. might be a potential anti-cancer agent for the treatment of breast cancer.


  • Autophagy and Cancer

    by Berrin Tuğrul, Erdal Balcan, Beyhan Gürcü

    Programlanmış tip II hücre ölüm tipi olan otofaji kendi kendini yeme işlemidir. Açlık ve diğer stres durumlarında biyomoleküllerin yapı taşlarının bazal seviyelerini koruyan hücre içi bir geri dönüşüm sürecidir. Lizozom aracılı katabolik bir süreç olan otofaji hücresel homeostazın sürdürülmesinde önemli bir role sahiptir. Otofaji tiplerinden biri olan makrootofaji yolağı, iç ve dış sinyallerin uyarımı sonucunda hücre içi sindirilecek materyal (yanlış katlanmış ya da bozulmuş proteinler, hasarlı organeller, vb.) otofagozom içine alınarak, otofagozomun lizozomla birleşmesi sonucu lizozomal aktivite ile sindirilmesi sürecini içerir. Otofaji sinyal yolağı otofaji ile ilişkili genler (ATG’ler)’in ürünleri ile ilave proteinler ve otofaji ile ilişkili kinazlar tarafından düzenlenmektedir. Otofaji mekanizmasındaki bozukluklar kanserin de dahil olduğu çeşitli hastalıklarla ilişkilendirilmektedir. Tümör oluşumu sırasında otofajinin kanserin erken evresinde tümör baskılayıcı, ileri evrede ise tümörü teşvik edici ikili bir role sahip olduğu çeşitli çalışmalarla ortaya konmuştur. Otofajinin karmaşık yapısı ve kanserdeki bu ikili rolü sebebiyle mekanizmanın tam olarak aydınlatılması ve farklı kanserlerde hangi aşamada nasıl bir role sahip olduğunun belirlenmesi ya otofaji baskılayıcı ya da otofajiyi teşvik edici etkin tedavilerin geliştirilmesine olanak tanıyacaktır. Bu derlemede, makrootofaji sinyal yolağının moleküler mekanizması, otofajinin kanserdeki ikili rolü ve otofaji ile ilişkili kansere karşı geliştirilen tedavi yaklaşımları hakkında bilgiler verilmesi amaçlanmıştır.

  • Open Access

    Investigation of effect of vitamin D receptor, calcium-sensing receptor and β-catenin on cutaneous squamous cell carcinoma

    by Berrin Tuğrul, Sevinç Söylev, Peyker Temiz, Gülsüm Gençoğlan

    Background: Cutaneous squamous cell carcinoma (cSCC) is a malignant and invasive tumor which is originated from epidermis with a high incidence among non-melanoma skin cancers. The aim of this study was to determine whether vitamin D receptor (VDR), calcium-sensing receptor (CaSR) and beta catenin (β-catenin) proteins have an effect on cSCC. Materials and methods: VDR, CaSR and β-catenin proteins in tissue samples of cSCC and control group were analyzed by immunohistochemistry (IHC) and Western blotting (WB) method. IHC findings were statistically evaluated. Results: IHC staining density of VDR and β-catenin were higher in cSCC tissue samples than control. The difference between IHC staining density of VDR and β-catenin in the patient and the control groups were statistically significant (p = 0.021, p = 0.021, respectively), but not for CaSR (p = 0.237). While the VDR and β-catenin staining rates obtained by the IHC method could be supported by WB results, the WB bands for CaSR could not be shown. Conclusion: The findings suggest that VDR and β-catenin may have an effect on the disease. Further research is required to better understand the role of VDR and β-catenin together on cSCC.


  • Open Access

    Cytotoxic and Apoptotic Effects of Hydroxytyrosol on Ovarian Cancer Cell Lines: Relationship of Cytotoxic Effect with ERK 1/2 Pathway

    by Latife Merve Oktay, Berrin Tuğrul

    SUMMARY Objective: It has been shown that hydroxytryrosol (HT) has antitumoral, anti-proliferative and apoptotic effects on various cancer cell line types. In this study, we investigated cytotoxic and apoptotic effects of HTon human ovarian cancer cell lines OVCAR-3 and MDAH-2774 and relationship of its cytotoxic effects with phosphatidylinositol 3-kinase/Akt (PI3K/Akt) and extracellular signal-regulated kinase 1/2 (ERK 1/2) signaling pathways. Method: XTT cell proliferation kit, Cell Death Detection Elisa Plus Kit and Human Apoptosis Array test were used to determine the cytotoxic and apoptotic effects of HT in OVCAR-3 and MDAH-2774 cell lines at 24, 48, 72 and 96 hours (h). Effect of HT on PI3K/Akt and ERK 1/2 signaling pathways were investigated by using specific inhibitors of these pathways. Results: IC50 values of HT were found to be 102.3 μM in MDAH-2774 cells at 72 h and 51.5 μM in OVCAR-3 cells at 96 h. Highest apoptotic effect was seen at 100 μM concentration in OVCAR-3 cells at 96 h and at 50 μM at 72 h in MDAH-2774. HT increased the levels of pro-apoptotic molecules including Bad, Bax, active caspase-3, Htra2/Omi and of proapoptotic death receptors TRAIL R1/DR4, TRAIL R2/DR5, FAS/TNFRSF6 and decreased Survivin levels in MDAH-2774 cells. In OVCAR-3 cells, HT decreased Bcl-2, pro-caspase 3 and CIAP-1, CIAP-2, XIAP, Livin, Survivin levels and increased cytochrome-c level. The cell vitality was increased in both of the cell lines as the result of the treatment with HT and FR180204. Conclusions: These results show that HT has potential cytotoxic and apoptotic effect on OVCAR-3 and MDAH-2774 cells. In both cell lines, the cytotoxic effect of HT could be ocur inhibiting through ERK 1/2 signaling pathway. Keywords: apoptosis; cell line; cytotoxicity; ERK 1/2 pathway; hydroxytyrosol; ovarian cancer   ÖZET Amaç: Hiroksitirozolün (HT) çeşitli kanser hücre hatları üzerindeki antitümoral, çoğalmayı inhibe etme ve apoptotik etkileri olduğu gösterilmiştir. Bu çalışmada, insan yumurtalık kanser hücre hatları OVCAR-3 ve MDAH-2774 üzerinde HT’nin sitotoksik ve apoptotik etkilerini ve onun sitotoksik etkisinin fosfotidil 3-kinaz/Akt (PI3K/Akt) ve hücre dışı sinyalle düzenlenen kinaz 1/2 (ERK 1/2) ile ilişkisini araştırdık. Yöntem:  HT’nin, 24, 48, 72 ve 96 saatlik OVCAR-3 ve MDAH-2774 hücre kültürleri üzerinde sitotoksik ve apoptotik etkilerini belirlemek için, XTT hücre canlılık testi, hücre ölümünü belirleyen ELISA plus ve insan apoptoz array testi kullanıldı. HT’nin sitotoksik etkisinin PI3K/Akt ve ERK 1/2 sinyal yolakları ile ilişkisi, yolakların spesifik inhibitörleri kullanılarak araştırıldı. Bulgular: HT’nin IC50 değeri MDAH-2774 hücrelerinde 72. saatte 102.3 μM, OVCAR-3 hücrelerinde 96. saatte 51.5 μM bulundu. En yüksek apoptotik etki OVCAR-3 için 96. saatte 100 μM ve MDAH-2774 için 72. saatte 50 μM’da görüldü. HT, MDAH-2774 hücrelerinde Bad, Bax, aktif kaspaz-3, Htra2/Omi’nin dahil olduğu pro-apoptotik moleküllerin seviyesini ve TRAIL R1/DR4, TRAIL R2/DR5, FAS/TNFRSF6 içeren pro-apoptotik ölüm reseptörlerinin seviyesini artırdı. OVCAR-3 hücrelerinde HT, Bcl-2, pro-caspase 3 and CIAP-1, CIAP-2, XIAP, Livin, Survivin seviyelerini azalttı ve sitokrom-c seviyesini arttırdı. Hücre canlılığı, HT ile FR180204 uygulamasının sonucunda her iki hücre hattında arttı. Sonuç: Bu sonuçlar HT’nin OVCAR-3 ve MDAH-2774 hücreleri üzerinde sitotoksik ve apoptotik etki potansiyeline sahip olduğunu göstermektedir. Her iki kültür hücrelerinde HT’nin sitotoksik etkisi ERK 1/2 sinyal yolağını inhibe ederek gerçekleşiyor olabilir. Anahtar sözcükler: apoptoz; ERK 1/2 yolağı; hidroksitirozol; hücre hattı; sitotoksisite; yumurtalık kanseri